RESEARCH-USE BIOSIMILAR ANTIBODY
Betifisolimab
Monoclonal antibody · IgG1
Betifisolimab (MSB-2311) is a humanized monoclonal antibody directed against the immunosuppressive ligand PD-L1. Betifisolimab has the potential for advanced solid tumors and hematological malignancies research.
TARGETPDL1
YMonoclonal antibody
CATALOGSC-BS-725
CATALOG NUMBERSC-BS-725
MOLECULAR WEIGHTApprox. 146.14 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Betifisolimab (MSB-2311) is a humanized monoclonal antibody directed against the immunosuppressive ligand PD-L1. Betifisolimab has the potential for advanced solid tumors and hematological malignancies research.
Betifisolimab is a recombinant research-use antibody directed against PDL1.